Trial · NCT00557310
Results by group33
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 33
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline in Surface-to-Curve Ratio (SCR) in the Distal Radius at Month 18 Endpoint | Teriparatide | 4.53 | Standard Error 4.89 | percent (%) change of ratio | |
| Percent Change From Baseline in Surface-to-Curve Ratio (SCR) in the Distal Radius at Month 24 Endpoint | Teriparatide | 1.44 | Standard Error 6.88 | % change of ratio | |
| Percent Change From Baseline in Cortical Thickness (CT) in the Distal Radius at Month 18 and 24 Endpoint | Teriparatide | 18 month percent change (n=25) | -0.61 | Standard Error 2.56 | % change of millimeter (mm) |
| Percent Change From Baseline in Cortical Thickness (CT) in the Distal Radius at Month 18 and 24 Endpoint | Teriparatide | 24 month percent change (n=21) | -0.22 | Standard Error 2.59 | % change of millimeter (mm) |
| Percent Change From Baseline in Topological Erosion Index (TEI) in the Distal Radius at Month 18 and 24 Endpoint | Teriparatide | 18 month percent change (n=25) | 3.36 | Standard Error 3.31 | % change of ratio |
| Percent Change From Baseline in Topological Erosion Index (TEI) in the Distal Radius at Month 18 and 24 Endpoint | Teriparatide | 24 month percent change (n=21) | 8.46 | Standard Error 4.63 | % change of ratio |
| Percent Change From Baseline in Bone Volume (BV)/Total Volume (TV) Ratio in the Distal Radius at Month 18 and 24 Endpoint | Teriparatide | 18 month percent change (n=25) | 0.36 | Standard Error 1.85 | % change of ratio |
| Percent Change From Baseline in Bone Volume (BV)/Total Volume (TV) Ratio in the Distal Radius at Month 18 and 24 Endpoint | Teriparatide | 24 month percent change (n=21) | -3.14 | Standard Error 2.40 | % change of ratio |
| Percent Change From Baseline in Surface-to-Curve Ratio (SCR) at Month 3, 6, 12, 18 and 24 Endpoint | Teriparatide | 3 month percent change (n=32) | -3.38 | Standard Error 3.46 | % change of ratio |
| Percent Change From Baseline in Surface-to-Curve Ratio (SCR) at Month 3, 6, 12, 18 and 24 Endpoint | Teriparatide | 6 month percent change (n=30) | 0.43 | Standard Error 4.05 | % change of ratio |
| Percent Change From Baseline in Surface-to-Curve Ratio (SCR) at Month 3, 6, 12, 18 and 24 Endpoint | Teriparatide | 12 month percent change (n=28) | 2.36 | Standard Error 4.56 | % change of ratio |
| Percent Change From Baseline in Surface-to-Curve Ratio (SCR) at Month 3, 6, 12, 18 and 24 Endpoint | Teriparatide | 18 month percent change (n=25) | 4.53 | Standard Error 4.89 | % change of ratio |
| Percent Change From Baseline in Surface-to-Curve Ratio (SCR) at Month 3, 6, 12, 18 and 24 Endpoint | Teriparatide | 24 month percent change (n=21) | 1.44 | Standard Error 6.88 | % change of ratio |
| Percent Change From Baseline in Volumetric Bone Mineral Density (BMD) of Lumbar Spine at Month 18 Endpoint | Teriparatide | 10.05 | Standard Error 1.55 | % change of mg/cm³ | |
| Percent Change From Baseline in Volumetric Bone Mineral Density (BMD) of Hip at Month 18 Endpoint | Teriparatide | 2.22 | Standard Error 0.88 | % change of mg/cm³ | |
| Percent Change From Baseline in the Estimate of Bone Strength of Lumbar Spine at Month 18 Endpoint | Teriparatide | 17.43 | Standard Error 2.57 | % change of Newtons | |
| Percent Change From Baseline in the Estimate of Bone Strength of Hip at Month 18 Endpoint | Teriparatide | 2.54 | Standard Error 1.18 | % change of Newtons | |
| Percent Change From Baseline in Areal BMD at the Lumbar Spine at Month 18 and 24 Endpoint | Teriparatide | 18 month percent change (n=28) | 7.215 | Standard Error 1.166 | % change of g/square centimeter (g/cm²) |
| Percent Change From Baseline in Areal BMD at the Lumbar Spine at Month 18 and 24 Endpoint | Teriparatide | 24 month percent change (n=25) | 8.702 | Standard Error 0.939 | % change of g/square centimeter (g/cm²) |
| Percent Change From Baseline in Areal BMD at the Femoral Neck at Month 18 and 24 Endpoint | Teriparatide | 18 month percent change (n=28) | 2.792 | Standard Error 0.998 | % change of g/cm² |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00557310/results